% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Mayer:164189,
author = {Mayer, Geert and Happe, Svenja and Evers, Stefan and
Hermann, Wiebke and Jansen, Sabine and Kallweit, Ulf and
Muntean, Maria-Lucia and Pöhlau, Dieter and Riemann, Dieter
and Saletu, Michael and Schichl, Melanie and Schmitt,
Wolfgang J and Sixel-Döring, Friederike and Young, Peter},
title = {{I}nsomnia in neurological diseases.},
journal = {Neurological research and practice},
volume = {3},
number = {1},
issn = {2524-3489},
address = {[London]},
publisher = {BioMed Central},
reportid = {DZNE-2022-00845},
pages = {15},
year = {2021},
note = {(CC BY)},
abstract = {Insomnia is defined as difficulties of initiating and
maintaining sleep, early awakening and poor subjective sleep
quality despite adequate opportunity and circumstances for
sleep with impairment of daytime performance. These
components of insomnia - namely persistent sleep
difficulties despite of adequate sleep opportunity resulting
in daytime dysfunction - appear secondary or co-morbid to
neurological diseases. Comorbid insomnia originates from
neurodegenerative, inflammatory, traumatic or ischemic
changes in sleep regulating brainstem and hypothalamic
nuclei with consecutive changes of neurotransmitters.
Symptoms of neurological disorders (i.e motor deficits),
co-morbidities (i.e. pain, depression, anxiety) and some
disease-specific pharmaceuticals may cause insomnia and/or
other sleep problems.This guideline focuses on insomnias in
headaches, neurodegenerative movement disorders, multiple
sclerosis, traumatic brain injury, epilepsies, stroke,
neuromuscular disease and dementia.The most important new
recommendations are: Cognitive behavioral therapy (CBTi) is
recommended to treat acute and chronic insomnia in headache
patients. Insomnia is one of the most frequent sleep
complaints in neurodegenerative movement disorders. Patients
may benefit from CBTi, antidepressants (trazodone, doxepin),
melatonin and gaba-agonists. Insomnia is a frequent
precursor of MS symptoms by up to 10 years. CBTi is
recommended in patients with MS, traumatic brain injury and.
Melatonin may improve insomnia symptoms in children with
epilepsies. Patients with insomnia after stroke can be
treated with benzodiazepine receptor agonists and sedating
antidepressants. For patients with dementia suffering from
insomnia trazodone, light therapy and physical exercise are
recommended.},
keywords = {Classifications (Other) / Cognitive behavioral therapy
(Other) / Comorbid diseases (Other) / Diagnostic instruments
(Other) / Insomnia (Other) / Neurological diseases (Other) /
Therapeutic recommendations (Other)},
cin = {AG Teipel},
ddc = {610},
cid = {I:(DE-2719)1510100},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33691803},
pmc = {pmc:PMC7944611},
doi = {10.1186/s42466-021-00106-3},
url = {https://pub.dzne.de/record/164189},
}